According to the University of California San Francisco, Huntington’s disease affects one in every 10,000 to 20,000 people in ...

(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...

Prilenia Therapeutics is planning to file its Huntington’s disease ... HD address the symptoms of the disease, and pridopidine is vying to become the first drug approved to slow down its ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...

Despite reporting positive Phase II results for its lead candidate last year, Vaccinex will soon no longer be a publicly ...

TRIMTECH Therapeutics’s incredible $31million seed funding haul will be deployed to develop treatments for severe ...

While announcing criminal charges in the case, Attorney General Rob Bonta said the recent seizure of more than 50 pounds of ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

Dear Savvy Senior, At age 70, I’ve become more and more forgetful lately and am concerned it may be an early sign of dementia ...

Even if you are experiencing memory problems, it doesn’t necessarily mean you have dementia. Many memory problems are brought ...